Tautomycetin
Tautomycetin is a polyketide natural product that is produced by certain strains of the bacteria Streptomyces. It is a potent protein phosphatase inhibitor, specifically targeting protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A). Tautomycetin has been studied for its potential use in cancer therapy due to its ability to inhibit cell growth and induce apoptosis in cancer cells.
Chemical Structure[edit]
Tautomycetin has a complex molecular structure that includes a 20-membered macrocyclic lactone ring, a dihydroxy-methyl-glutaric acid side chain, and a tetrahydrofuran ring. The macrocyclic lactone ring is highly oxygenated, with seven hydroxyl groups and two carbonyl groups. The dihydroxy-methyl-glutaric acid side chain is attached to the macrocyclic ring via an ester linkage.
Biosynthesis[edit]
The biosynthesis of tautomycetin involves a polyketide synthase (PKS) pathway. The PKS pathway is a complex series of enzyme-catalyzed reactions that assemble simple carbon units into a complex polyketide structure. The PKS pathway for tautomycetin involves the sequential addition of acetate and malonate units to a growing polyketide chain.
Biological Activity[edit]
Tautomycetin is a potent inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), two important protein phosphatases involved in cell cycle regulation. By inhibiting these enzymes, tautomycetin disrupts the normal cell cycle and induces apoptosis in cancer cells. This makes tautomycetin a potential candidate for use in cancer therapy.
Potential Therapeutic Uses[edit]
Due to its potent inhibitory activity against PP1 and PP2A, tautomycetin has been studied for its potential use in cancer therapy. In preclinical studies, tautomycetin has been shown to inhibit the growth of various types of cancer cells, including breast cancer cells, prostate cancer cells, and leukemia cells. However, further research is needed to fully understand the potential therapeutic uses of tautomycetin.
See Also[edit]
This chemical compound related article is a stub. You can help WikiMD by expanding it.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
